Search

  

Corporate News

Lumenis is Proud to Support the First International Scar Treatment Conference in Israel

February 22, 2017 – Yokneam, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, announced that it will be supporting the first International Scar Treatment Conference in Israel, which will be held in Tel Aviv, on February 22nd, 2017.

Lumenis Advances Endometriosis Therapy and Awareness

Providing Gynecologists and their Patients True Added Value with a Delicate and Precise Surgical Tool and a New Online Resource for Patient Education and Support

November 14, 2016 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications articulates its commitment to providing gynecologists with a flexible CO2 laser solution designed for minimally invasive surgical approach to effectively and delicately remove endometriosis lesions while protecting valuable surrounding healthy tissue and preserving its functionality. Focusing on gynecological health and addressing various indications, Lumenis will showcase its 360° approach to gynecology and innovative CO2 laser portfolio at the American Association of Gynecologic Laparoscopists (AAGL) Annual Meeting, taking place November 14-18, 2016 in Orlando, Florida.

PB-2007295 rev A

Lumenis Announces Participation in First Educational Course at the 17th European Burns Association Congress

September 26, 2016 – Yokneam, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced it will be the first laser company to participate in the European Burn Association’s Educational course on 'Post Burn Reconstruction' at the 17th European Burn Association (EBA) Congress, being held in Birmingham, U.K. from September 26-27, 2016.

PB-2007437 rev A

A New Solution for Delicate and Precise Middle Ear Surgery: Delivering Optimal Laser Performance with OtoLase™

As an Innovative Leader in ENT, Lumenis Promotes Fiber-based Solutions to Enable Physicians Unlimited Flexibility and a Whole New Sphere of Improved Patient Care

September 16, 2016 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announces the introduction of OtoLase™, the new otology designated enhancement for the AcuPulse™ family of products. Specifically designed for enhanced precision and ease of use in middle ear surgery, the innovative OtoLase will be showcased at the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) Annual meeting 2016, being held in San Diego on September 18-21, 2016.

PB-2007294 rev A

Lumenis Introduces a 360° Solution for Women’s Gynecological Health at the 2016 International Urogynecological Association Meeting

Enabling Gynecologists and Urogynecologists to Offer Advanced Treatments for a Variety of Gynecological and Vaginal Health Conditions and Expand their Practice Offering

August 2, 2016 – Yokneam, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced the introduction of FemTouch™, an enhancement to the comprehensive offering for women’s gynecological health, along with the AcuPulse™ CO2 laser product family, at the upcoming 41st Annual International Urogynecological Association (IUGA) meeting, being held in Cape Town, South Africa from August 2-6, 2016.  

PB-2007427 REV A

Lumenis Launches UltraPulse® DUO at the ELS Congress and Invites ENT Physicians to Join LINK, A New Revolutionary Platform for Clinical Knowledge Sharing

The Company’s Comprehensive Set of Activities at the ELS Congress Strengthens Collaboration with the ENT Surgical Community

June 8, 2016 – Yokneam, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, launches the UltraPulse DUO CO2 advanced laser platform alongside LINK, a new communication channel for ENT medical professionals, at the 11th congress of the European Laryngological Society (ELS), taking place in Genoa, Italy, from June 8-11, 2016.  

PB-2006190 rev A

New Clinical Results on Use of UltraPulse® in Treating Patients Suffering from Chronic Radiation Dermatitis to be presented at the French Laser Society Meeting

Lumenis Laser System Used to Treat Radiation Injuries Associated with Cancer Treatment

June 2, 2016 – Yokneam, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced that results from the clinical case series analyzing the UltraPulse® CO2 laser system will be presented at the upcoming Journee Parisienne Du Laser, a French laser society meeting that will be held in Paris from June 3-4, 2016. The UltraPulse, high energy short pulsed fractional CO2 laser, was used in a combination of laser treatments on Vietnamese patients suffering from chronic radiation dermatitis –- radiation skin damage or radiation burns -- caused by radiotherapy in treating benign childhood hemangiomas. 

PB-2007436 rev A

Lumenis Offers Advanced Surgical Solutions alongside Comprehensive CO2 Laser Educational Sessions at COSM 2016

Lumenis Collaborates With the ENT Surgical Community on DUO Product Line Training

May 18, 2016 – Yokneam, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced it will be collaborating with leading educational institutes, residents and fellows to provide training sessions for the state-of-the-art UltraPulse DUO and AcuPulse DUO surgical solutions, at the annual Combined Otolaryngology Spring Meetings (COSM), being held in Chicago from May 18-22, 2016.  

PB-2006003 rev A

Lumenis to Present Interim Safety and Efficacy Results of IPL with OPT™ for Treating Dry Eye at Major Ophthalmology Meeting

May 5, 2016 - Yokneam, Israel 

Lumenis, Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, will present interim results of a multicenter prospective clinical trial designed to study the safety and efficacy of Optimal Pulse Technology (OPTTM), the next generation of Intense Pulse Light (IPL) technology, for treating Dry Eye Disease (DED). Data from the trial, being led by Steven J. Dell, MD, of Dell Laser Consultants in Austin, Texas, will be presented at a conference of anterior segment ophthalmologists being held May 6-10 in New Orleans, LA. 

PB-2005801 REV A

Lumenis Expands its Urology Portfolio with the Introduction of Three New Additions to the Pulse Family of Holmium Lasers

With the Unveiling of the Pulse 100H, 50H and 30H, Lumenis Delivers a Series of Innovative Platforms for Urology

May 6, 2016 – Yokneam, Israel 

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced the launch of Lumenis Pulse™ 100H, Pulse™ 50H and Pulse™ 30H holmium laser solutions, at the 111th American Urological Association (AUA) Annual Meeting, being held in San Diego from
May 6-10, 2016.  

PB-2005908 rev A

Lumenis Proudly Announces its Laser Technologies will be the Focus of More than 20 Presentations at the American Society of Laser Medicine and Surgery Conference (ASLMS)

New Data from Two Clinical Evaluations on LightSheer® INFINITY™ to also be Presented

March 30, 2016 – Yokneam, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, proudly announced today that the company’s laser aesthetic portfolio will be the focus of more than 20 presentations at the American Society of Laser Medicine and Surgery (ASLMS) Annual Conference, being held March 30 to April 3, 2016 at the Hynes Convention Center in Boston, MA. This also includes new data from two clinical studies conducted using the latest breakthrough in hair reduction technology, the LightSheer® INFINITY™ laser system.

PB-2007435 rev A

RSS
12345